2022-RA-1552-ESGO Survival after hyperthermic intraperitoneal chemotherapy in kazakhstani women with ovarian cancer: KazIOR experience

Dilyara Kaidarova; Raikhan Bolatbekova; Yerlan Kukubassov; Tolkyn Sadykova; Alima Satanova

doi:10.1136/ijgc-2022-ESGO.742

Article info

Ovarian cancer

2022-RA-1552-ESGO Survival after hyperthermic intraperitoneal chemotherapy in kazakhstani women with ovarian cancer: KazIOR experience

Free

Authors

Dilyara Kaidarova Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan PubMed articles Google scholar articles
Raikhan Bolatbekova Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan PubMed articles Google scholar articles
Yerlan Kukubassov Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan PubMed articles Google scholar articles
Tolkyn Sadykova Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan PubMed articles Google scholar articles
Alima Satanova Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan PubMed articles Google scholar articles

Citation

Kaidarova D, Bolatbekova R, Kukubassov Y, et al

2022-RA-1552-ESGO Survival after hyperthermic intraperitoneal chemotherapy in kazakhstani women with ovarian cancer: KazIOR experience

International Journal of Gynecologic Cancer 2022;32:A349.

Publication history

First published October 20, 2022.

Online issue publication

October 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password